FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016562008> ?p ?o ?g. }

• W2016562008 endingPage "808" @default.
• W2016562008 startingPage "801" @default.
• W2016562008 abstract "Objective Our aim was to investigate possible effects of sequence variations in ABCC2, encoding the multidrug resistance-associated protein 2 (MRP2), on the pharmacokinetics of the MRP2 substrate pravastatin. Methods Deoxyribonucleic acid samples of 41 healthy volunteers, in whom SLCO1B1 single nucleotide polymorphisms (SNPs) and haplotypes had previously been found to be associated with increased plasma pravastatin concentrations, were investigated. Each study participant had ingested a single 40-mg dose of pravastatin followed by blood sampling for pharmacokinetic characterization in standardized conditions. The exons, exon–intron boundaries, promoter region and 3′-untranslated region of the ABCC2 gene of six individuals with the highest and six individuals with the lowest pravastatin area under the plasma concentration–time curve (AUC) values were sequenced. Results Of the 26 sequence variations found, the synonymous c.1446C>G SNP was observed heterozygously in three (50%) of the six individuals with a low pravastatin AUC and in none (0%) of the six individuals with a high AUC (P=0.06 for allele frequency). The remaining 29 participants were then also genotyped for c.1446C>G, but none of them carried the SNP. In addition, the effect of c.1446C>G on MRP2 mRNA expression was investigated in 93 human liver samples. A multiple linear regression analysis in the 41 participants with pravastatin pharmacokinetic data indicated that the ABCC2 c.1446C>G SNP and the previously identified SLCO1B1 haplotype *17 were independent predictors of the AUC0–12 and Cmax of pravastatin (r2=32 and 29%, respectively) (P<0.01). In the participants heterozygous for the ABCC2 c.1446C>G SNP (n=3), who were not carriers of the SLCO1B1*17 haplotype, the AUC0−12 and Cmax of pravastatin were 67 and 68% lower than in those carrying neither the SLCO1B1*17 haplotype nor the ABCC2 c.1446C>G SNP (n=35) (P<0.05). MRP2 mRNA expression was 95% higher in livers with the c.1446CG genotype (n=7) than in those with the c.1446CC genotype (n=86) (P<0.05). Conclusions These results support the idea that the ABCC2 c.1446C>G SNP is associated with reduced systemic exposure to pravastatin as a consequence of increased MRP2 expression. The underlying mechanism may involve either a modulating effect of the SNP on mRNA stability or linkage to other polymorphism(s) acting at the transcriptional level." @default.
• W2016562008 created "2016-06-24" @default.
• W2016562008 creator A5017846615 @default.
• W2016562008 creator A5023657124 @default.
• W2016562008 creator A5044688765 @default.
• W2016562008 creator A5046639877 @default.
• W2016562008 creator A5047851431 @default.
• W2016562008 creator A5056451757 @default.
• W2016562008 creator A5068055000 @default.
• W2016562008 creator A5075309527 @default.
• W2016562008 creator A5086202633 @default.
• W2016562008 creator A5089475081 @default.
• W2016562008 creator A5090364666 @default.
• W2016562008 date "2006-11-01" @default.
• W2016562008 modified "2023-10-15" @default.
• W2016562008 title "Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics" @default.
• W2016562008 cites W1569115457 @default.
• W2016562008 cites W1649837843 @default.
• W2016562008 cites W1978006382 @default.
• W2016562008 cites W1988985926 @default.
• W2016562008 cites W1994212671 @default.
• W2016562008 cites W1997538585 @default.
• W2016562008 cites W2014565106 @default.
• W2016562008 cites W2020620545 @default.
• W2016562008 cites W2027504487 @default.
• W2016562008 cites W2033582596 @default.
• W2016562008 cites W2039986849 @default.
• W2016562008 cites W2042745755 @default.
• W2016562008 cites W2046429605 @default.
• W2016562008 cites W2046788693 @default.
• W2016562008 cites W2048593300 @default.
• W2016562008 cites W2087015670 @default.
• W2016562008 cites W2099891679 @default.
• W2016562008 cites W2107703226 @default.
• W2016562008 cites W2111020493 @default.
• W2016562008 cites W2127191771 @default.
• W2016562008 cites W2133282432 @default.
• W2016562008 cites W2139121124 @default.
• W2016562008 cites W2155568044 @default.
• W2016562008 cites W2161972125 @default.
• W2016562008 cites W2164258980 @default.
• W2016562008 doi "https://doi.org/10.1097/01.fpc.0000230422.50962.91" @default.
• W2016562008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17047488" @default.
• W2016562008 hasPublicationYear "2006" @default.
• W2016562008 type Work @default.
• W2016562008 sameAs 2016562008 @default.
• W2016562008 citedByCount "99" @default.
• W2016562008 countsByYear W20165620082012 @default.
• W2016562008 countsByYear W20165620082013 @default.
• W2016562008 countsByYear W20165620082014 @default.
• W2016562008 countsByYear W20165620082015 @default.
• W2016562008 countsByYear W20165620082016 @default.
• W2016562008 countsByYear W20165620082017 @default.
• W2016562008 countsByYear W20165620082018 @default.
• W2016562008 countsByYear W20165620082019 @default.
• W2016562008 countsByYear W20165620082020 @default.
• W2016562008 countsByYear W20165620082021 @default.
• W2016562008 countsByYear W20165620082022 @default.
• W2016562008 countsByYear W20165620082023 @default.
• W2016562008 crossrefType "journal-article" @default.
• W2016562008 hasAuthorship W2016562008A5017846615 @default.
• W2016562008 hasAuthorship W2016562008A5023657124 @default.
• W2016562008 hasAuthorship W2016562008A5044688765 @default.
• W2016562008 hasAuthorship W2016562008A5046639877 @default.
• W2016562008 hasAuthorship W2016562008A5047851431 @default.
• W2016562008 hasAuthorship W2016562008A5056451757 @default.
• W2016562008 hasAuthorship W2016562008A5068055000 @default.
• W2016562008 hasAuthorship W2016562008A5075309527 @default.
• W2016562008 hasAuthorship W2016562008A5086202633 @default.
• W2016562008 hasAuthorship W2016562008A5089475081 @default.
• W2016562008 hasAuthorship W2016562008A5090364666 @default.
• W2016562008 hasConcept C104317684 @default.
• W2016562008 hasConcept C112705442 @default.
• W2016562008 hasConcept C134018914 @default.
• W2016562008 hasConcept C135763542 @default.
• W2016562008 hasConcept C139275648 @default.
• W2016562008 hasConcept C149011108 @default.
• W2016562008 hasConcept C153209595 @default.
• W2016562008 hasConcept C180754005 @default.
• W2016562008 hasConcept C197754878 @default.
• W2016562008 hasConcept C22979827 @default.
• W2016562008 hasConcept C2776598434 @default.
• W2016562008 hasConcept C2778163477 @default.
• W2016562008 hasConcept C2779519902 @default.
• W2016562008 hasConcept C36201501 @default.
• W2016562008 hasConcept C44312359 @default.
• W2016562008 hasConcept C54355233 @default.
• W2016562008 hasConcept C86803240 @default.
• W2016562008 hasConcept C98274493 @default.
• W2016562008 hasConceptScore W2016562008C104317684 @default.
• W2016562008 hasConceptScore W2016562008C112705442 @default.
• W2016562008 hasConceptScore W2016562008C134018914 @default.
• W2016562008 hasConceptScore W2016562008C135763542 @default.
• W2016562008 hasConceptScore W2016562008C139275648 @default.
• W2016562008 hasConceptScore W2016562008C149011108 @default.
• W2016562008 hasConceptScore W2016562008C153209595 @default.
• W2016562008 hasConceptScore W2016562008C180754005 @default.
• W2016562008 hasConceptScore W2016562008C197754878 @default.

• next